z-logo
open-access-imgOpen Access
Z-drugs and risk for falls and fractures in older adults—a systematic review and meta-analysis
Author(s) -
Nir Treves,
Amichai Perlman,
Lital Kolenberg Geron,
Angham Asaly,
Ilan Matok
Publication year - 2017
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afx167
Subject(s) - medicine , zolpidem , meta analysis , odds ratio , confidence interval , zopiclone , medline , subgroup analysis , insomnia , psychiatry , political science , law
zolpidem, zopiclone, eszopiclone and zaleplon, also known as 'Z-drugs', are commonly used as alternatives to benzodiazepines (BZDs) to treat insomnia. Z-drugs are often perceived as safer than BZDs. We conducted a systematic review and meta-analysis evaluating the association between Z-drugs and fracutres, falls and injuries.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom